Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India ; volume:07 ; number:01 ; year:2018 ; pages:11-15
South Asian journal of cancer ; 07, Heft 01 (2018), 11-15
- Contributor
-
Babu, K. Govind
Chaudhuri, Tamojit
Lakshmaiah, K. C.
Dasappa, Lokanatha
Jacob, Linu Abraham
Suresh Babu, M. C.
Rudresha, A. H.
Lokesh, K. N.
Rajeev, L. K.
- DOI
-
10.4103/sajc.sajc_8_17
- URN
-
urn:nbn:de:101:1-2021021720403618648083
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Babu, K. Govind
- Chaudhuri, Tamojit
- Lakshmaiah, K. C.
- Dasappa, Lokanatha
- Jacob, Linu Abraham
- Suresh Babu, M. C.
- Rudresha, A. H.
- Lokesh, K. N.
- Rajeev, L. K.
Other Objects (12)
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial